Tapewire

Nasdaq · USD

NMRA

Neumora Therapeutics, Inc.

Export transactions ↓
Tapewire entity
6115
SEC CIK
0001885522
Parsed reports
118

Last 12 months

Inside the activity.

0 purchase rows · 16 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202604
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 2026011
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 27, 2026 Filed May 29, 2026 20:22 UTC GrantStock Option (Right to Buy) · Derivative 80,000 $0.00 Strike: $1.86 $0.00
Disclosure

SEC source: 0001610717-26-000171 · form4.xml · derivative · entry 1

Piacquad David · CIK 0001602343 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2036-05-26

F1 · derivative.exercise_date: 100% of the shares subject to the option vest on the earlier of (i) the one year anniversary of May 27, 2026 or (ii) immediately prior to the next Annual Meeting following May 27, 2026.

Read SEC document
May 27, 2026 Filed May 29, 2026 20:21 UTC
Halawa AlaaDirector
GrantStock Option (Right to Buy) · Derivative 80,000 $0.00 Strike: $1.86 $0.00
Disclosure

SEC source: 0001610717-26-000170 · form4.xml · derivative · entry 1

Halawa Alaa · CIK 0001992622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2036-05-26

F1 · derivative.exercise_date: 100% of the shares subject to the option vest on the earlier of (i) the one year anniversary of May 27, 2026 or (ii) immediately prior to the next Annual Meeting following May 27, 2026.

Read SEC document
May 27, 2026 Filed May 29, 2026 20:21 UTC
Ho MaykinDirector
GrantStock Option (Right to Buy) · Derivative 80,000 $0.00 Strike: $1.86 $0.00
Disclosure

SEC source: 0001610717-26-000169 · form4.xml · derivative · entry 1

Ho Maykin · CIK 0001646395 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2036-05-26

F1 · derivative.exercise_date: 100% of the shares subject to the option vest on the earlier of (i) the one year anniversary of May 27, 2026 or (ii) immediately prior to the next Annual Meeting following May 27, 2026.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 22:07 UTC SaleCommon Stock 6,165 $3.56 $21,916.58
Disclosure

SEC source: 0001610717-26-000054 · form4.xml · nonDerivative · entry 1

Aurora Daljit Singh · CIK 0001793971 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,770

F1 · kind: The shares were sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 22:06 UTC
Pinto JoshuaPresident
SaleCommon Stock 5,967 $3.54 $21,093.35
Disclosure

SEC source: 0001610717-26-000053 · form4.xml · nonDerivative · entry 1

Pinto Joshua · CIK 0001992595 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,783

F1 · kind: The shares were sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 22:05 UTC
BERNS PAUL LDirector · See Remarks
SaleCommon Stock 9,819 $3.51 $34,458.80
Disclosure

SEC source: 0001610717-26-000052 · form4.xml · nonDerivative · entry 1

BERNS PAUL L · CIK 0001202769 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,395,185

F1 · kind: The shares were sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

F2 · price: This transaction was executed in multiple trades in prices ranging from $3.48 to $3.545, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
February 17, 2026 Filed Feb 19, 2026 22:04 UTC SaleCommon Stock 1,436 $3.57 $5,119.34
Disclosure

SEC source: 0001610717-26-000051 · form4.xml · nonDerivative · entry 1

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,034

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on August 30, 2024, which provides for the automatic sale of shares of common stock that would otherwise be issuable on each vesting date of a covered restricted stock unit in an amount necessary to satisfy the applicable withholding obligation.

Read SEC document
January 08, 2026 Filed Jan 9, 2026 21:19 UTC GrantStock Option (Right to Buy) · Derivative 750,000 $0.00 Strike: $2.33 $0.00
Disclosure

SEC source: 0001610717-26-000011 · form4.xml · derivative · entry 1

Aurora Daljit Singh · CIK 0001793971 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 750,000

Underlying: Common Stock · 750,000 shares

Expires 2036-01-08

F1 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from January 8, 2026 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
January 08, 2026 Filed Jan 9, 2026 21:20 UTC GrantStock Option (Right to Buy) · Derivative 350,000 $0.00 Strike: $2.33 $0.00
Disclosure

SEC source: 0001610717-26-000014 · form4.xml · derivative · entry 1

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common Stock · 350,000 shares

Expires 2036-01-08

F1 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from January 8, 2026 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
January 08, 2026 Filed Jan 9, 2026 21:18 UTC
Duncan JasonSee Remarks
GrantStock Option (Right to Buy) · Derivative 750,000 $0.00 Strike: $2.33 $0.00
Disclosure

SEC source: 0001610717-26-000010 · form4.xml · derivative · entry 1

Duncan Jason · CIK 0001741553 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 750,000

Underlying: Common Stock · 750,000 shares

Expires 2036-01-08

F1 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from January 8, 2026 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
January 08, 2026 Filed Jan 9, 2026 21:18 UTC
Pinto JoshuaPresident
GrantStock Option (Right to Buy) · Derivative 1,200,000 $0.00 Strike: $2.33 $0.00
Disclosure

SEC source: 0001610717-26-000009 · form4.xml · derivative · entry 1

Pinto Joshua · CIK 0001992595 · President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,200,000

Underlying: Common Stock · 1,200,000 shares

Expires 2036-01-08

F1 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from January 8, 2026 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
January 08, 2026 Filed Jan 9, 2026 21:17 UTC
BERNS PAUL LDirector · See Remarks
GrantStock Option (Right to Buy) · Derivative 1,650,000 $0.00 Strike: $2.33 $0.00
Disclosure

SEC source: 0001610717-26-000008 · form4.xml · derivative · entry 1

BERNS PAUL L · CIK 0001202769 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,650,000

Underlying: Common Stock · 1,650,000 shares

Expires 2036-01-08

F1 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from January 8, 2026 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 21:39 UTC SaleCommon Stock 114,703 $2.68 $307,025.52
Disclosure

SEC source: 0001610717-25-000378 · form4.xml · nonDerivative · entry 1

Aurora Daljit Singh · CIK 0001793971 · See Remarks

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 0

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on April 22, 2024.

F2 · price: This transaction was executed in multiple trades in prices ranging from $2.65 to $2.81, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3 · ownership.nature: Shares held by Aurora Family Trust.

Read SEC document
October 27, 2025 Filed Oct 29, 2025 23:22 UTC
Burow KristinaDirector · 10% owner
PurchaseCommon Stock 1,915,700 $2.61 $4,999,977.00
Disclosure

SEC source: 0001012975-25-000681 · form4.xml · nonDerivative · entry 1

Burow Kristina · CIK 0001569248 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By ARCH Venture Fund XII, L.P.

Disclosed balance after: 6,046,907

F1 · ownership.nature: Represents shares held directly by ARCH Venture Fund XII, L.P. (ARCH XII). ARCH Venture Partners XII, L.P. (AVP XII LP) is the general partner of ARCH XII. ARCH Venture Partners XII, LLC (AVP XII LLC) is the general partner of AVP XII LP. Keith Crandell, Kristina Burow, Steven Gillis and Robert Nelsen comprise the investment committee of AVP XII LLC (the AVP XII LLC Committee Members). Each of AVP XII LP and AVP XII LLC may be deemed to beneficially own the shares held by ARCH XII, and each of the AVP XII LLC Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH XII. Each of AVP XII LP, AVP XII LLC and the AVP XII LLC Committee Members disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any.

Read SEC document
October 27, 2025 Filed Oct 29, 2025 23:21 UTC
GILLIS STEVEN10% owner
NELSEN ROBERT10% owner
BYBEE CLINTON10% owner
PurchaseCommon Stock 1,915,700 $2.61 $4,999,977.00
Disclosure

SEC source: 0001012975-25-000680 · form4.xml · nonDerivative · entry 1

ARCH Venture Partners XII, LLC · CIK 0001979548 · 10% owner

ARCH Venture Partners XII, L.P. · CIK 0001979765 · 10% owner

ARCH Venture Fund XII, L.P. · CIK 0001906837 · 10% owner

CRANDELL KEITH · CIK 0001219039 · 10% owner

GILLIS STEVEN · CIK 0001229592 · 10% owner

NELSEN ROBERT · CIK 0001219042 · 10% owner

BYBEE CLINTON · CIK 0001219043 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By ARCH Venture Fund XII, L.P.

Disclosed balance after: 6,046,907

F1 · ownership.nature: Represents shares held directly by ARCH Venture Fund XII, L.P. (ARCH XII). ARCH Venture Partners XII, L.P. (AVP XII LP) is the general partner of ARCH XII. ARCH Venture Partners XII, LLC (AVP XII LLC) is the general partner of AVP XII LP. Keith Crandell, Kristina Burow, Steven Gillis and Robert Nelsen comprise the investment committee of AVP XII LLC (the AVP XII LLC Committee Members). Each of AVP XII LP and AVP XII LLC may be deemed to beneficially own the shares held by ARCH XII, and each of the AVP XII LLC Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH XII. Each of AVP XII LP, AVP XII LLC and the AVP XII LLC Committee Members disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any.

Read SEC document
October 27, 2025 Filed Oct 29, 2025 23:19 UTC PurchaseCommon Stock 1,915,700 $2.61 $4,999,977.00
Disclosure

SEC source: 0001012975-25-000679 · form4.xml · nonDerivative · entry 1

ARCH Venture Partners X, LLC · CIK 0001769012 · 10% owner

ARCH Venture Fund X, L.P. · CIK 0001757011 · 10% owner

ARCH Venture Partners X, L.P. · CIK 0001782583 · 10% owner

ARCH Venture Fund X Overage, L.P. · CIK 0001757017 · 10% owner

ARCH Venture Partners X Overage, L.P. · CIK 0001768905 · 10% owner

ARCH Venture Partners VII, LLC · CIK 0001544443 · 10% owner

ARCH Venture Partners VII, L.P. · CIK 0001544444 · 10% owner

ARCH Venture Fund VII, L.P. · CIK 0001402439 · 10% owner

ARCH Venture Partners VIII, LLC · CIK 0001616165 · 10% owner

ARCH Venture Fund VIII Overage, L.P. · CIK 0001617237 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By ARCH Venture Fund XII, L.P.

Disclosed balance after: 6,046,907

F1 · ownership.nature: Represents shares held directly by ARCH Venture Fund XII, L.P. (ARCH XII). ARCH Venture Partners XII, L.P. (AVP XII LP) is the general partner of ARCH XII. ARCH Venture Partners XII, LLC (AVP XII LLC) is the general partner of AVP XII LP. Keith Crandell, Kristina Burow, Steven Gillis and Robert Nelsen comprise the investment committee of AVP XII LLC (the AVP XII LLC Committee Members). Each of AVP XII LP and AVP XII LLC may be deemed to beneficially own the shares held by ARCH XII, and each of the AVP XII LLC Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH XII. Each of AVP XII LP, AVP XII LLC and the AVP XII LLC Committee Members disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:31 UTC GrantStock Option (Right to Buy) · Derivative 400,000 Not disclosed Strike: $0.72 Not disclosed
Disclosure

SEC source: 0000950170-25-079926 · ownership.xml · derivative · entry 10

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires 2035-02-13

F7 · derivative.exercise_price: On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged.

F6 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 13, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:31 UTC GrantStock Option (Right to Buy) · Derivative 41,250 Not disclosed Strike: $0.72 Not disclosed
Disclosure

SEC source: 0000950170-25-079926 · ownership.xml · derivative · entry 9

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,250

Underlying: Common Stock · 41,250 shares

Expires 2034-02-14

F7 · derivative.exercise_price: On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged.

F5 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:31 UTC GrantStock Option (Right to Buy) · Derivative 28,675 Not disclosed Strike: $0.72 Not disclosed
Disclosure

SEC source: 0000950170-25-079926 · ownership.xml · derivative · entry 8

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,675

Underlying: Common Stock · 28,675 shares

Expires 2033-06-23

F7 · derivative.exercise_price: On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged.

F4 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date'), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:31 UTC GrantStock Option (Right to Buy) · Derivative 38,234 Not disclosed Strike: $0.72 Not disclosed
Disclosure

SEC source: 0000950170-25-079926 · ownership.xml · derivative · entry 7

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,234

Underlying: Common Stock · 38,234 shares

Expires 2033-02-17

F7 · derivative.exercise_price: On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:31 UTC GrantStock Option (Right to Buy) · Derivative 85,391 Not disclosed Strike: $0.72 Not disclosed
Disclosure

SEC source: 0000950170-25-079926 · ownership.xml · derivative · entry 6

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,391

Underlying: Common Stock · 85,391 shares

Expires 2032-01-27

F7 · derivative.exercise_price: On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from December 20, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:31 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 400,000 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-079926 · ownership.xml · derivative · entry 5

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 400,000 shares

Expires 2035-02-13

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged.

F6 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 13, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:31 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 41,250 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-079926 · ownership.xml · derivative · entry 4

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 41,250 shares

Expires 2034-02-14

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged.

F5 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:31 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 28,675 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-079926 · ownership.xml · derivative · entry 3

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 28,675 shares

Expires 2033-06-23

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged.

F4 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date'), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:31 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 38,234 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-079926 · ownership.xml · derivative · entry 2

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 38,234 shares

Expires 2033-02-17

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:31 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 85,391 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-079926 · ownership.xml · derivative · entry 1

Milligan Michael Lee · CIK 0001993953 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 85,391 shares

Expires 2032-01-27

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 7, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from December 20, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC
Duncan JasonSee Remarks
GrantStock Option (Right to Buy) · Derivative 500,000 Not disclosed Strike: $0.72 Not disclosed
Disclosure

SEC source: 0000950170-25-079924 · ownership.xml · derivative · entry 4

Duncan Jason · CIK 0001741553 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2035-02-13

F4 · derivative.exercise_price: On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 13, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC
Duncan JasonSee Remarks
GrantStock Option (Right to Buy) · Derivative 400,000 Not disclosed Strike: $0.72 Not disclosed
Disclosure

SEC source: 0000950170-25-079924 · ownership.xml · derivative · entry 3

Duncan Jason · CIK 0001741553 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires 2033-12-11

F4 · derivative.exercise_price: On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from December 11, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC
Duncan JasonSee Remarks
Disposition to issuerStock Option (Right to Buy) · Derivative 500,000 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-079924 · ownership.xml · derivative · entry 2

Duncan Jason · CIK 0001741553 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 500,000 shares

Expires 2035-02-13

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 13, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC
Duncan JasonSee Remarks
Disposition to issuerStock Option (Right to Buy) · Derivative 400,000 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-079924 · ownership.xml · derivative · entry 1

Duncan Jason · CIK 0001741553 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 400,000 shares

Expires 2033-12-11

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from December 11, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC GrantStock Option (Right to Buy) · Derivative 80,000 $0.00 Strike: $0.72 $0.00
Disclosure

SEC source: 0000950170-25-079925 · ownership.xml · derivative · entry 7

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2035-05-27

F5 · derivative.exercise_date: 100% of the shares subject to the option vest on the earlier of (i) the one year anniversary of May 28, 2025 or (ii) immediately prior to the next Annual Meeting following May 28, 2025.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC GrantStock Option (Right to Buy) · Derivative 28,571 Not disclosed Strike: $0.72 Not disclosed
Disclosure

SEC source: 0000950170-25-079925 · ownership.xml · derivative · entry 6

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,571

Underlying: Common Stock · 28,571 shares

Expires 2034-06-13

F4 · derivative.exercise_price: On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of (i) one year anniversary of June 13, 2024 or (ii) immediately prior to the next Annual Meeting following June 13, 2024.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC GrantStock Option (Right to Buy) · Derivative 27,802 Not disclosed Strike: $0.72 Not disclosed
Disclosure

SEC source: 0000950170-25-079925 · ownership.xml · derivative · entry 5

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,802

Underlying: Common Stock · 27,802 shares

Expires 2033-09-14

F4 · derivative.exercise_price: On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC GrantStock Option (Right to Buy) · Derivative 85,586 Not disclosed Strike: $0.72 Not disclosed
Disclosure

SEC source: 0000950170-25-079925 · ownership.xml · derivative · entry 4

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,586

Underlying: Common Stock · 85,586 shares

Expires 2031-04-23

F4 · derivative.exercise_price: On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 28,571 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-079925 · ownership.xml · derivative · entry 3

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 28,571 shares

Expires 2034-06-13

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of (i) one year anniversary of June 13, 2024 or (ii) immediately prior to the next Annual Meeting following June 13, 2024.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 27,802 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-079925 · ownership.xml · derivative · entry 2

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 27,802 shares

Expires 2033-09-14

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 85,586 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-079925 · ownership.xml · derivative · entry 1

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 85,586 shares

Expires 2031-04-23

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: The stock option is fully vested and exercisable.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC
Burow KristinaDirector · 10% owner
GrantStock Option (Right to Buy) · Derivative 80,000 $0.00 Strike: $0.72 $0.00
Disclosure

SEC source: 0000950170-25-079923 · ownership.xml · derivative · entry 5

Burow Kristina · CIK 0001569248 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2035-05-27

F5 · derivative.exercise_date: 100% of the shares subject to the option vest on the earlier of (i) the one year anniversary of May 28, 2025 or (ii) immediately prior to the next Annual Meeting following May 28, 2025.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC
Burow KristinaDirector · 10% owner
GrantStock Option (Right to Buy) · Derivative 28,571 Not disclosed Strike: $0.72 Not disclosed
Disclosure

SEC source: 0000950170-25-079923 · ownership.xml · derivative · entry 4

Burow Kristina · CIK 0001569248 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,571

Underlying: Common Stock · 28,571 shares

Expires 2034-06-13

F4 · derivative.exercise_price: On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of (i) one year anniversary of June 13, 2024 or (ii) immediately prior to the next Annual Meeting following June 13, 2024.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC
Burow KristinaDirector · 10% owner
GrantStock Option (Right to Buy) · Derivative 46,455 Not disclosed Strike: $0.72 Not disclosed
Disclosure

SEC source: 0000950170-25-079923 · ownership.xml · derivative · entry 3

Burow Kristina · CIK 0001569248 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,455

Underlying: Common Stock · 46,455 shares

Expires 2033-09-14

F4 · derivative.exercise_price: On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: 1/36th of the shares subject to the option vest on each monthly anniversary measured from September 14, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC
Burow KristinaDirector · 10% owner
Disposition to issuerStock Option (Right to Buy) · Derivative 28,571 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-079923 · ownership.xml · derivative · entry 2

Burow Kristina · CIK 0001569248 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 28,571 shares

Expires 2034-06-13

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of (i) one year anniversary of June 13, 2024 or (ii) immediately prior to the next Annual Meeting following June 13, 2024.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC
Burow KristinaDirector · 10% owner
Disposition to issuerStock Option (Right to Buy) · Derivative 46,455 Not disclosed Strike: $1.69 Not disclosed
Disclosure

SEC source: 0000950170-25-079923 · ownership.xml · derivative · entry 1

Burow Kristina · CIK 0001569248 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 46,455 shares

Expires 2033-09-14

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: 1/36th of the shares subject to the option vest on each monthly anniversary measured from September 14, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC GrantStock Option (Right to Buy) · Derivative 1,000,000 Not disclosed Strike: $0.72 Not disclosed
Disclosure

SEC source: 0000950170-25-079922 · ownership.xml · derivative · entry 16

Aurora Daljit Singh · CIK 0001793971 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,000,000

Underlying: Common Stock · 1,000,000 shares

Expires 2035-02-13

F9 · derivative.exercise_price: On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged.

F8 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 13, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC GrantStock Option (Right to Buy) · Derivative 195,000 Not disclosed Strike: $0.72 Not disclosed
Disclosure

SEC source: 0000950170-25-079922 · ownership.xml · derivative · entry 15

Aurora Daljit Singh · CIK 0001793971 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 195,000

Underlying: Common Stock · 195,000 shares

Expires 2034-02-14

F9 · derivative.exercise_price: On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged.

F7 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC GrantStock Option (Right to Buy) · Derivative 29,737 Not disclosed Strike: $0.72 Not disclosed
Disclosure

SEC source: 0000950170-25-079922 · ownership.xml · derivative · entry 14

Aurora Daljit Singh · CIK 0001793971 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 29,737

Underlying: Common Stock · 29,737 shares

Expires 2033-06-23

F9 · derivative.exercise_price: On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: The stock option is fully vested and exercisable.

F4 · ownership.nature: Shares held by Aurora Family Trust, which members of the Reporting Person's immediate family are the sole beneficiaries.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC GrantStock Option (Right to Buy) · Derivative 72,221 Not disclosed Strike: $0.72 Not disclosed
Disclosure

SEC source: 0000950170-25-079922 · ownership.xml · derivative · entry 13

Aurora Daljit Singh · CIK 0001793971 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,221

Underlying: Common Stock · 72,221 shares

Expires 2033-06-23

F9 · derivative.exercise_price: On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged.

F6 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC GrantStock Option (Right to Buy) · Derivative 136,210 Not disclosed Strike: $0.72 Not disclosed
Disclosure

SEC source: 0000950170-25-079922 · ownership.xml · derivative · entry 12

Aurora Daljit Singh · CIK 0001793971 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 136,210

Underlying: Common Stock · 136,210 shares

Expires 2033-01-19

F9 · derivative.exercise_price: On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: The stock option is fully vested and exercisable.

F4 · ownership.nature: Shares held by Aurora Family Trust, which members of the Reporting Person's immediate family are the sole beneficiaries.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC GrantStock Option (Right to Buy) · Derivative 207,901 Not disclosed Strike: $0.72 Not disclosed
Disclosure

SEC source: 0000950170-25-079922 · ownership.xml · derivative · entry 11

Aurora Daljit Singh · CIK 0001793971 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 207,901

Underlying: Common Stock · 207,901 shares

Expires 2033-01-19

F9 · derivative.exercise_price: On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged.

F5 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from February 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC GrantStock Option (Right to Buy) · Derivative 137,538 Not disclosed Strike: $0.72 Not disclosed
Disclosure

SEC source: 0000950170-25-079922 · ownership.xml · derivative · entry 10

Aurora Daljit Singh · CIK 0001793971 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 137,538

Underlying: Common Stock · 137,538 shares

Expires 2031-09-20

F9 · derivative.exercise_price: On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged.

F3 · derivative.exercise_date: The stock option is fully vested and exercisable.

F4 · ownership.nature: Shares held by Aurora Family Trust, which members of the Reporting Person's immediate family are the sole beneficiaries.

Read SEC document
May 28, 2025 Filed May 30, 2025 22:30 UTC GrantStock Option (Right to Buy) · Derivative 40,890 Not disclosed Strike: $0.72 Not disclosed
Disclosure

SEC source: 0000950170-25-079922 · ownership.xml · derivative · entry 9

Aurora Daljit Singh · CIK 0001793971 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,890

Underlying: Common Stock · 40,890 shares

Expires 2031-09-20

F9 · derivative.exercise_price: On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026.

F2 · price: On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 9, all other terms of the option remain unchanged.

F1 · derivative.exercise_date: 25% of the shares subject to the option vest on the first anniversary measured from August 2, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.